BioCentury
ARTICLE | Financial News

NeurogesX financial update

April 30, 2012 7:00 AM UTC

NeurogesX received a letter from NASDAQ indicating that the company has not regained compliance with the minimum $50 million market value requirement for continued listing. The company intends to requ...